MiMedx Group, Inc.
MDXG
$4.27
$0.071.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 9.10% | -50.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.10% | -50.05% | |||
| Cost of Revenue | 15.04% | -8.85% | |||
| Gross Profit | 6.63% | -57.97% | |||
| SG&A Expenses | 12.30% | -27.15% | |||
| Depreciation & Amortization | -3.32% | 133.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.38% | -22.65% | |||
| Operating Income | -15.06% | -176.14% | |||
| Income Before Tax | -15.97% | -170.34% | |||
| Income Tax Expenses | 34.24% | -167.70% | |||
| Earnings from Continuing Operations | -36.65% | -171.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -36.65% | -171.49% | |||
| EBIT | -15.06% | -176.14% | |||
| EBITDA | -17.34% | -159.40% | |||
| EPS Basic | -37.16% | -171.35% | |||
| Normalized Basic EPS | -16.59% | -170.11% | |||
| EPS Diluted | -37.16% | -173.27% | |||
| Normalized Diluted EPS | -16.59% | -171.11% | |||
| Average Basic Shares Outstanding | -0.44% | 0.24% | |||
| Average Diluted Shares Outstanding | -0.44% | -1.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||